BioCentury
ARTICLE | Clinical News

BioChaperone Lispro: Phase Ib started

February 8, 2016 8:00 AM UTC

Adocia and Eli Lilly began a double-blind, 3-period crossover, German Phase Ib trial to compare 3 single doses of 0.1, 0.2 and 0.4 U/kg BioChaperone Lispro every 1-14 days vs. 1 single dose of 0.2 U/k...